American College of Clinical Pharmacy
      Search      Cart
         

Health Outcomes PRN Focus Session -- Design and Implementation of Health Outcomes Research Using Electronic Medical Records

Tuesday, October 10, 2017 from 1:15 PM to 2:45 PM MST at Phoenix Convention Center North Building Street Level: Meeting Room 125

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-17-158-L04-P
Activity Type: A Knowledge-Based Activity

This session doubles as an elective for the Research and Scholarship Academy programming. To receive credit toward a certificate of completion, participants must be enrolled in the ACCP Academy and sign the sign-in sheet provided during the session.

Speakers
  • Diana M. Sobieraj, Pharm.D.Moderator: Diana M. Sobieraj, Pharm.D.
    Assistant Professor, University of Connecticut School of Pharmacy, Hartford, Connecticut

Introduction
1:15 PM

Learning Objectives
1. Explain the purpose and structure of the ACCP PBRN.
2. Compare and contrast research questions that are an appropriate fit for conduct within the ACCP PBRN.
Pearls for the Design and Implementation of EMR-Based Health Outcomes Research
1:20 PM

Speakers
  • Alan J. Zillich, Pharm.D., FCCP, BCPS, BCACPSpeaker: Alan J. Zillich, Pharm.D., FCCP, BCPS, BCACP
    Professor and Head, Department of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, Indiana; Research Scientist, Roudebush VA Medical Center, Center for Health Information and Communication
      View Biography


Learning Objectives
1. Describe Federal funding mechanisms available for pharmacists-scientists planning practice-based research projects and the process of securing Federal funding for research.
2. Describe the nuances pertaining to completing Federally-funded studies within the ACCP PBRN.
Lessons Learned -- Pharmacy Residency-Focused Research
1:50 PM

Speakers
  • Michael Nailor, Pharm.D.Speaker: Michael Nailor, Pharm.D.


Learning Objectives
1. Describe pharmaceutical industry funding mechanisms available for pharmacists-scientists planning practice-based research projects and the process of securing pharmaceutical industry funding for research.
2. Describe the nuances pertaining to completing pharmaceutical industry-funded studies within the ACCP PBRN.
Lessons Learned -- National Closed-System Research
2:00 PM

Speakers
  • Christopher R. Frei, Pharm.D., FCCP, BCPSSpeaker: Christopher R. Frei, Pharm.D., FCCP, BCPS
    Associate Professor, Pharmacotherapy Division, College of Pharmacy, University of Texas at Austin; and Adjunct Faculty Member, Department of Medicine, Division of Infectious Diseases and Pharmacotherapy Education & Research Center, School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas
      View Biography


Learning Objectives
1. Describe other (e.g., Foundation, academia) funding mechanisms available for pharmacists-scientists planning practice-based research projects and the process of securing other types of funding for research.
2. Describe the nuances pertaining to completing studies funded by other sources within the ACCP PBRN.
Lessons Learned -- PBRN-Focused Research
2:20 PM

Speakers
  • Christopher M. Bland, Pharm.D., FIDSA, BCPSSpeaker: Christopher M. Bland, Pharm.D., FIDSA, BCPS
    Clinical Associate Professor, University of Georgia College of Pharmacy, Southeast Georgia Campus, Savannah, Georgia
      View Biography


Learning Objectives
1. Compare and contrast ways in which federal, industry, and foundation funding influences the completion of research studies within the ACCP PBRN.
2. Compare and contrast ways in which federal, industry, and foundation funding influences the completion of research studies within the ACCP PBRN.
Panel Discussion
2:35 PM

Learning Objectives
1. Describe the role of the ACCP PBRN Community Advisory Panel.
2. Describe the 2016-2017 charge for the ACCP PBRN Advisory Panel and provide an update.